Discovery Grants support researchers conducting preliminary and proof-of-concept studies in psoriatic disease and related comorbidities to establish new programs competitive for long-term funding.
The closed 2026 cycle notice has been replaced with a 2027 application deadline of January 15, 2027, at 11:59 p.m. ET. The $75,000 annual cap now permits up to 10% indirect costs if required by your institution, replacing the direct-costs-only rule; indirect costs are not mandatory.
Funder: National Psoriasis Foundation
Due Dates: January 15, 2027, at 11:59 p.m. Eastern Time (Application) | June 30, 2027 (Anticipated notification)
Funding Amounts: Up to $75,000 for one year, including institution-required indirect costs up to 10%
Summary: Supports preliminary and proof-of-concept research in psoriatic disease to establish programs competitive for long-term funding.
Key Information: PIs must hold an M.D., Ph.D., or equivalent degree and have institutional eligibility to apply as principal investigator.
The National Psoriasis Foundation (NPF) Discovery Grants support researchers exploring preliminary ideas and conducting proof-of-concept experiments in psoriatic disease and related comorbidities. The goal is to establish new research programs positioned to compete for subsequent funding from the National Institutes of Health, industry, or similar sources.
Applications addressing all aspects of psoriatic disease are encouraged, including basic science, technology development, public health, and clinical research. Review prioritizes meaningful collaborations that could open significant new lines of inquiry into root causes and potential cures. Applicants are encouraged to consider published research gaps and priorities, including thematic areas in NPF’s FY25–29 Strategic Plan.